First Time Loading...

Meridian Bioscience Inc
NASDAQ:VIVO

Watchlist Manager
Meridian Bioscience Inc Logo
Meridian Bioscience Inc
NASDAQ:VIVO
Watchlist
Price: 33.97 USD Market Closed
Updated: May 14, 2024

Meridian Bioscience Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Meridian Bioscience Inc
Research & Development Peer Comparison

Comparables:
COO
XRAY
ALGN
LNTH

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Meridian Bioscience Inc
NASDAQ:VIVO
Research & Development
-$24.3m
CAGR 3-Years
-11%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Cooper Companies Inc
NYSE:COO
Research & Development
-$145.3m
CAGR 3-Years
-16%
CAGR 5-Years
-11%
CAGR 10-Years
-9%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Research & Development
-$180m
CAGR 3-Years
-3%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Align Technology Inc
NASDAQ:ALGN
Research & Development
-$351.2m
CAGR 3-Years
-23%
CAGR 5-Years
-21%
CAGR 10-Years
-22%
Lantheus Holdings Inc
NASDAQ:LNTH
Research & Development
-$95.2m
CAGR 3-Years
-35%
CAGR 5-Years
-40%
CAGR 10-Years
-16%

See Also

What is Meridian Bioscience Inc's Research & Development?
Research & Development
-24.3m USD

Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Research & Development amounts to -24.3m USD.

What is Meridian Bioscience Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-9%

Over the last year, the Research & Development growth was -2%. The average annual Research & Development growth rates for Meridian Bioscience Inc have been -11% over the past three years , -9% over the past five years .